Showing 481 - 500 results of 1,388 for search '"immunosuppression"', query time: 0.07s Refine Results
  1. 481

    The Regulation Effect of α7nAChRs and M1AChRs on Inflammation and Immunity in Sepsis by Song Hu, Yundong Wang, Hongbing Li

    Published 2021-01-01
    “…The inflammatory storm in the early stage and immunosuppression in the late stage are responsible for the high mortality rates and multiple organ dysfunction in sepsis. …”
    Get full text
    Article
  2. 482

    A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment by G. Manenti, F. Di Giuliano, A. Bindi, V. Liberto, V. Funel, F. G. Garaci, R. Floris, G. Simonetti

    Published 2013-01-01
    “…A risk factor for the development of PCNSL is immunodeficiency, which includes congenital disorders, iatrogenic immunosuppression, and HIV. The clinical course is rapidly fatal; these patients usually present signs of increased intracranial pressure, nausea, papilledema, vomiting, and neurological and neuropsychiatric symptoms. …”
    Get full text
    Article
  3. 483

    Use of Extracorporeal Membrane Oxygenation in Pneumocystis Pneumonia of an Infant with AIDS by Grégoire Cane, Arnaud De Boislambert, Charlotte Sgro, Pierre Lavedan, Hélène Foulgoc, Nadir Tafer, Alexandre Ouattara

    Published 2020-01-01
    “…Pneumocystis pneumonia is a common complication of cellular immunosuppression and may trigger severe pulmonary complications. …”
    Get full text
    Article
  4. 484

    IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES. by Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria

    Published 2024-06-01
    “…Front-line therapy includes daily plasma exchange (PEX) with fresh frozen plasma replacement and immunosuppression with corticosteroids. Caplacizumab is recently added to the front-line therapy. …”
    Get full text
    Article
  5. 485

    Human induced pluripotent stem cell–derived therapies for regeneration after central nervous system injury by Stephen Vidman, Yee Hang Ethan Ma, Nolan Fullenkamp, Giles W. Plant

    Published 2025-11-01
    “…Lastly, host immune responses to allogeneic grafts must be thoroughly characterized and further developed to reduce the need for immunosuppression. Translation to a clinical setting will involve careful consideration when assessing both physiologic and functional outcomes. …”
    Get full text
    Article
  6. 486

    Humoral and Cellular Immune Regulation in Albino Rat Exposed to Glyphosate and Aluminum Phosphide by Ujuamala Ezeani, Onyemaechi Afonne, Michael Ezeani

    Published 2024-12-01
    “…Additionally, there was a notable reduction in CD4+ levels at the second and third months post-exposure (p=0.001 and p<0.001, respectively).Conclusion: This study identified a deregulation of the immune system characterized by a progressive immunosuppression of CD4 T cell counts, indicating a down regulation of antibody-mediated (humoral) immune responses alongside an up regulation of cytotoxic T cells. …”
    Get full text
    Article
  7. 487

    Marek's disease virus-1 unique gene LORF1 is involved in viral replication and MDV-1/Md5-induced atrophy of the bursa of Fabricius. by Chenyi Bao, Jun Chu, Qi Gao, Shasha Yang, Xiaoyu Gao, Wenwen Chen, Fuchun Yang, Fei Jiang, Chenxi Tong, Mingyi Lei, Linlin Jiao, Jitong Li, Kexin Wei, Xue Lian, Kai Li, Suresh Kumar Tikoo, Nikolaus Osterrieder, Lorne A Babiuk, Yufeng Li, Yong-Sam Jung, Yingjuan Qian

    Published 2025-02-01
    “…Marek's disease virus (MDV), an alphaherpesvirus, causes severe immunosuppression and T cell lymphomas in chickens, known as Marek's disease (MD), an economically important poultry disease primarily controlled by vaccination. …”
    Get full text
    Article
  8. 488

    Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists by R. Kizlaitienė, D. Mickevičienė, L. Malcienė, N. Giedraitienė, R. Balnytė, D. Jatužis

    Published 2024-03-01
    “…This makes cladribine convenient for patients with multiple comorbidities, difficulties in adhering to their prescribed treatment regimen, those planning a pregnancy, or those for whom long-term immunosuppression is undesirable. Cladribine tablets are denoted by good safety characteristics, with the most prominent adverse effect being lymphopenia, which does not lead to an increased risk of infections other than Herpes zoster. …”
    Get full text
    Article
  9. 489

    Collapsing glomerulopathy associated with parvovirus B19 and systemic lupus erythematosus in a patient with APOL1 high-risk variant for nephropathy by Thaíza Passaglia Bernardes, Thalita Alvarenga Ferradosa Paula, Gabriel Teixeira Montezuma Sales, Patrícia Varela Calais, Renato Demarchi Foresto, Luiz Antonio Moura, Marcelino de Souza Durão Junior, João Bosco Pesquero, Gianna Mastroianni Kirsztajn

    Published 2025-01-01
    “…Treatment can be challenging in such a context, as no antiviral drug is efficient and immunosuppression has no discernable benefit, although steroid use was efficient in treating renal manifestations in this case.…”
    Get full text
    Article
  10. 490

    Low-Grade Inflammation and Spinal Cord Injury: Exercise as Therapy? by Eduardo da Silva Alves, Valdir de Aquino Lemos, Francieli Ruiz da Silva, Fabio Santos Lira, Ronaldo Vagner Thomathieli dos Santos, João Paulo Pereira Rosa, Erico Caperuto, Sergio Tufik, Marco Tulio de Mello

    Published 2013-01-01
    “…A decrease in sympathetic activity contributes to immunosuppression due to the lower activation of immune cells in the blood. …”
    Get full text
    Article
  11. 491

    The effect of the use of omeprazole versus famotidine on the kidney transplant function: a randomized controlled study by Miłosz Miedziaszczyk, Marek Karczewski, Ilona Idasiak-Piechocka

    Published 2025-01-01
    “…A randomized study was conducted in 24 adult patients with stable kidney transplant function who received a standard triple immunosuppression regimen. Patients were assigned to the group I (n = 12) additionally receiving omeprazole (20 mg) or the group II (n = 12) receiving famotidine (20 mg). …”
    Get full text
    Article
  12. 492

    Crusted Demodicosis in an Immunocompetent Pediatric Patient by Guillermo Antonio Guerrero-González, Maira Elizabeth Herz-Ruelas, Minerva Gómez-Flores, Jorge Ocampo-Candiani

    Published 2014-01-01
    “…The development of symptoms in this patient could be secondary to local immunosuppression caused by the chronic use of topical steroids.…”
    Get full text
    Article
  13. 493
  14. 494

    Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial by Manisha Verma, Radi Zaki, Johnathan Sadeh, John P. Knorr, Mark Gallagher, Afshin Parsikia, Victor Navarro

    Published 2023-01-01
    “…Nonadherence to immunosuppression in liver transplant recipients (LTRs) leads to deterioration in health outcomes. …”
    Get full text
    Article
  15. 495

    Trends in Survival for Adult Organ Transplantation by Grant Patrick, BS, Brian Hickner, MD, Karthik Goli, BS, Liam D. Ferreira, MBA, John Goss, MD, Abbas Rana, MD

    Published 2024-03-01
    “…Continued advancements in allocation policy, immunosuppression, and improved care of patients on the waitlist may contribute to further progress in outcomes of all organs, but the increasing discrepancy in supply and demand of donor kidneys is alarming and has impeded the progress of kidney intent-to-treat survival.…”
    Get full text
    Article
  16. 496

    Relationship of smokeless tobacco uses in the perspective of oral cancer: A global burden by Ashek Elahi Noor, Boyapati Ramanarayana

    Published 2024-06-01
    “…Chronic exposure to smokeless tobacco also induces a state of chronic inflammation and immunosuppression within the oral microenvironment, fostering a permissive milieu for carcinogenesis. …”
    Get full text
    Article
  17. 497

    Everolimus in Heart Transplantation: An Update by Stephan W. Hirt, Christoph Bara, Markus J. Barten, Tobias Deuse, Andreas O. Doesch, Ingo Kaczmarek, Uwe Schulz, Jörg Stypmann, Assad Haneya, Hans B. Lehmkuhl

    Published 2013-01-01
    “…Unless there are special considerations to take into account, all de novo heart transplant patients can be regarded as potential candidates for immunosuppression with everolimus and reduced-exposure calcineurin inhibitor therapy. …”
    Get full text
    Article
  18. 498

    Dexamethasone Coanalgesic Administration in Steroid Naïve and Steroid Non-Naïve Patients for the Prevention of Pain Flares after Palliative Radiotherapy for Bone Metastases by Dimitar G. Tonev, Silvia A. Lalova, Elena P. Petkova-Lungova, Nikolay V. Timenov, Gabriela M. Radeva, Todor G. Kundurzhiev

    Published 2022-01-01
    “…Lower dose 4 mg dexamethasone was revealed as a moderate analgesic agent in steroid naïve patients with no side effects, whereas in steroid non-naïve patients the predominantly higher dose 8 mg dexamethasone had minimal impact on pain flares prevention at the expense of more pronounced immunosuppression (P = 0.039). Conclusions. Irrespective of the supporting evidence of dexamethasone potential for prevention of RT-induced pain flare, our data failed to reveal its efficacy in the real practice world (a case mix of uncomplicated and complicated bone metastases). …”
    Get full text
    Article
  19. 499

    Mdivi-1 Protects CD4+ T Cells against Apoptosis via Balancing Mitochondrial Fusion-Fission and Preventing the Induction of Endoplasmic Reticulum Stress in Sepsis by You Wu, Yong-Ming Yao, He-Liang Ke, Lan Ying, Yao Wu, Guang-Ju Zhao, Zhong-Qiu Lu

    Published 2019-01-01
    “…Apoptosis of CD4+ T cells plays a central role in the progression of sepsis because it is associated with subsequent immunosuppression and the lack of specific treatment. Thus, developing therapeutic strategies to attenuate the apoptosis of CD4+ T cells in sepsis is critical. …”
    Get full text
    Article
  20. 500

    SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients with Immune Thrombocytopenia by Zhe Chen, Shufen Zhou, Jianyun Li, Hui Li, Can Huang, Qin Guo, Tiantian Zhang, Bingya Yang, Chuanqing Tu, Chengshan Guo

    Published 2021-01-01
    “…Mesenchymal stem cells (MSCs) have been demonstrated in the ability to induce immunosuppression, and stromal cell-derived factor-1α (SDF-1α) plays an important role in the migration and survival of MSCs. …”
    Get full text
    Article